Zhanna Jumadilova
Corporate Officer/Principal chez CLARUS THERAPEUTICS HOLDINGS, INC.
Profil
Zhanna Jumadilova is currently the Chief Clinical Development Officer at Clarus Therapeutics Holdings, Inc. Prior to this, he was the Vice President-Clinical Development at Insmed, Inc. from 2019 to 2021.
He also worked at AstraZeneca, Inc. as a General Manager.
Jumadilova holds an MBA from Joseph M.
Katz Graduate School of Business and a doctorate from Kazakh National Medical University.
Postes actifs de Zhanna Jumadilova
| Sociétés | Poste | Début |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 17/01/2022 |
Anciens postes connus de Zhanna Jumadilova
| Sociétés | Poste | Fin |
|---|---|---|
| INSMED INCORPORATED | Corporate Officer/Principal | 01/10/2021 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
Formation de Zhanna Jumadilova
| Joseph M. Katz Graduate School of Business | Masters Business Admin |
| Kazakh National Medical University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
